Adenomatous colonic polyps are rare in ulcerative colitis

Alimentary Pharmacology and Therapeutics

Volumn 19, Issue 8, 2004, Pages 879-887

  Kitiyakara, T ^a   Bailey, D M ^a   McIntyre, A S ^a   Gorard, D A ^a  

^a WYCOMBE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; CYCLOOXYGENASE 2; PROTEIN P16;

ADULT; ARTICLE; CANCER RISK; CLINICAL FEATURE; COLON POLYPOSIS; COLON RESECTION; COLONOSCOPY; COMPARATIVE STUDY; CONTROLLED STUDY; DEFECATION; DISEASE ASSOCIATION; ENTERITIS; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; PREVALENCE; PRIORITY JOURNAL; TREATMENT INDICATION; ULCERATIVE COLITIS;

ADENOMATOUS POLYPOSIS COLI; BIOPSY; COLITIS, ULCERATIVE; COLONIC NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INTESTINAL MUCOSA; MALE; MIDDLE AGED;

EID: 2042477354     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2004.01914.x     Document Type: Article

References (43)

1. Edwards FC, Truelove SC. Course and prognosis of ulcerative colitis, Part IV, Carcinoma of the colon. Gut 1964; 5: 15-22.
2. Gyde SN, Prior P, Allan RN, et al. Colorectal cancer in ulcerative colitis: a cohort study of primary referrals from three centres. Gut 1988; 29: 206-17.
3. Langholz E, Munkholm P, Davidsen M, Binder V. Colorectal cancer risk and mortality in patients with ulcerative colitis. Gastroenterology 1992; 103: 1444-51.
4. Ekbom A, Helmick C, Zack M, Adami HO. Ulcerative colitis and colorectal cancer. A population-based study. N Engl J Med 1990; 323: 1228-33.
5. Brostrom O, Lofberg R, Nordenvall B, Ost A, Hellers G. The risk of colorectal cancer in ulcerative colitis. An epidemiologic study. Scand J Gastroenterol 1987; 22: 1193-9.
6. Lennard-Jones JE, Melville DM, Morson BC, Ritchie JK, Williams CB. Precancer and cancer in extensive ulcerative colitis: findings among 401 patients over 22 years. Gut 1990; 31: 800-6.
7. Eaden JA, Abrams KR, Mayberry JF. The risk of colorectal cancer in ulcerative colitis: a meta-analysis. Gut 2001; 48: 526-35.
8. Rosenstock E, Farmer RG, Petras R, Sivak MV, Rankin GB, Sullivan BH. Surveillance for colonic carcinoma in ulcerative colitis. Gastroenterology 1985; 89: 1342-6.
9. Lofberg R, Brostrom O, Karlen P, Tribukait B, Ost A. Colonoscopic surveillance in long-standing total ulcerative colitis - a 15-year follow-up study. Gastroenterology 1990; 99: 1021-31.
10. Lennard-Jones JE, Ritchie JK, Morson BC, Williams CB. Cancer surveillance in ulcerative colitis: experience over 15 years. Lancet 1983; ii: 149-52.
11. Connell WR, Lennard-Jones JE, Williams CB, Talbot IC. Price AB, Wilkinson KH. Factors affecting the outcome of endoscopic surveillance for cancer in ulcerative colitis. Gastroenterology 1994; 107: 934-44.
12. Eaden JA, Mayberry JF. Guidelines for screening and surveillance of asymptomatic colorectal cancer in patients with inflammatory bowel disease. Gut 2002; 51(Suppl. V): v10-12.
13. Blackstone MO, Riddell RH, Rodgers BHG, Levin B. Dysplasia-associated lesion or mass (DALM) detected by colonoscopy in longstanding colitis. An indication for colectomy. Gastroenterology 1981; 80: 366-74.
14. Bernstein CN, Shanahan F, Weinstein WM. Are we telling patients the truth about surveillance colonoscopy in ulcerative colitis? Lancet 1994; 343: 71-4.
15. Engelsgjerd M, Farraye FA, Odze RD. Polypectomy may be adequate treatment for adenoma-like dysplastic lesions in chronic ulcerative colitis. Gastroenterology 1999; 117: 1288-94.
16. Rubin PH, Friedman S, Harpaz N, et al. Colonoscopic polypectomy in chronic colitis: conservative management after endoscopic resection of dysplastic polyps. Gastroenterology 1999; 117: 1295-300.
17. Riddell RH, Goldman H, Ransohoff DF, et al. Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical applications. Hum Pathol 1983; 14: 931-68.
18. Soetikno RM, Lin OS, Heidenreich PA, Young HS, Blackstone MO. Increased risk of colorectal neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis: a meta-analysis. Gastrointest Endosc 2002; 56: 48-54.
19. Askling J, Dickman PW, Karlen P, et al. Family history as a risk factor for colorectal cancer in inflammatory bowel disease. Gastroenterology 2001; 120: 1356-62.
20. Collins RH. Feldman M, Fordtran JS. Colon cancer, dysplasia and surveillance in ulcerative colitis: a critical review. N Engl J Med 1987; 316: 1654-8.
21. Gyde S. Screening for colorectal cancer in ulcerative colitis: dubious benefits and high costs. Gut 1990; 31: 1089-97.
22. Axon ATR. Cancer surveillance in ulcerative colitis - a time for reappraisal. Gut 1994; 35: 587-9.
23. Mayer R, Wong WD, Rothenberger DA, Goldberg SM, Madoff RD. Colorectal cancer in inflammatory bowel disease: a continuing problem. Dis Colon Rectum 1999; 42: 343-7.
24. Nugent FW, Haggitt RC, Gilpin PA. Cancer surveillance in ulcerative colitis. Gastroenterology 1991; 100: 1241-8.
25. Ritchie JK, Powell-Tuck J, Lennard-Jones JE. Clinical outcome of first ten years of ulcerative colitis and proctitis. Lancet 1978; 1: 1140-3.
26. Moum B, Ekbom A, Vatn MH. Change in the extent of colonoscopic and histological involvement in ulcerative colitis over time. Am J Gastroenterol 1999; 94: 1564-9.
27. Leidenius M, Kellokumpo I, Linden H, Taskinen E. The true extent of ulcerative colitis? A radiological, endoscopic and histological study. APMIS 1994; 102: 950-5.
28. Imperiale TF, Wagner DR, Lin CY, Larkin GN, Rogge JD, Ransohoff DF. Risk of advanced proximal neoplasms in asymptomatic adults according to the distal colorectal findings. N Engl J Med 2000; 343: 169-74.
29. Imperiale TF, Wagner DR, Lin CY, Larkin GN, Rogge JD, Ransohoff DF. Results of screening colonoscopy among persons 40-49 years of age. N Engl J Med 2002; 346: 1781-5.
30. Pinczowski D, Ekbom A, Baron J, Yuen J, Adami HO. Risk factors for colorectal cancer in patients with ulcerative colitis: a case-control study. Gastroenterology 1994; 107: 117-20.
31. Eaden J, Abrams K, Ekbom A, Jackson E, Mayberry J. Colorectal cancer prevention in ulcerative colitis: a case-control study. Aliment Pharmacol Ther 2000; 14: 145-53.
32. Reinacher-Schick A, Seidensticker F, Petrasch S, et al. Mesalazine changes apoptosis and proliferation in normal mucosa of patients with sporadic polyps of the large bowel. Endoscopy 2000; 32: 245-54.
33. Bus PJ, Nagtegaal ID, Verspaget HW, et al. Mesalazine-induced apoptosis of colorectal cancer: on the verge of a new chemopreventive era? Aliment Pharmacol Ther 1999; 13: 1397-402.
34. Reinacher-Schick A, Schoeneck A, Graeven U, Schwarte-Waldhoff I, Schmiegel W. Mesalazine causes a mitotic arrest and induces caspase-dependent apoptosis in colon carcinoma cells. Carcinogenesis 2003; 24: 443-51.
35. Odze RD, Brown CA, Hartmann CJ, Noffsinger AE, Fogt F. Genetic alterations in chronic ulcerative colitis-associated adenoma-like DALMS are similar to non-colitic sporadic adenomas. Am J Surg Pathol 2000; 24: 1209-16.
36. Torres C, Antonioli D, Odze RD. Polypoid dysplasia and adenomas in inflammatory bowel disease: a clinical, pathologic, and follow-up study of 89 polyps from 59 patients. Am J Surg Pathol 1998; 22: 275-84.
37. Odze RD. Adenomas and adenoma-like DALMs in chronic ulcerative colitis: a clinical, pathological, and molecular review. Am J Gastroenterol 1999; 94: 1746-50.
38. Fogt F, Alsaigh N. Polypoid dysplasias in ulcerative colitis and sporadic adenomas: genetic approach to the differential diagnosis (review). Oncol Reports 1999; 6: 721-5.
39. Selaru FM, Xu Y, Yin J, et al. Artificial neural networks distinguish among subtypes of neoplastic colorectal lesions. Gastroenterology 2002; 122: 606-13.
40. Fogt F, Poremba C, Shibao K, et al. Expression of survivin, YB-1, and KI-67 in sporadic adenomas and dysplasia-associated lesions or masses in ulcerative colitis. Appl Immunohistochem Mol Morph 2001; 9: 143-9.
41. Fogt F, Urbanski SJ, Sanders ME, et al. Distinction between dysplasia-associated lesion or mass (DALM) and adenoma in patients with ulcerative colitis. Hum Pathol 2000; 31: 288-91.
42. Ozde RD, Brien T, Brown CA, Hartmann CJ, Wellman A, Fogt F. Molecular alterations in chronic ulcerative colitis-associated and sporadic hyperplastic polyps: a comparative analysis. Am J Gastroenterol 2002; 97: 1235-42.
43. Dixon A, Wurm P, Robinson R, Hart A. Adenomatous polyps are rare in inflammatory bowel disease. Gut 2003; 52(Suppl. 1): A65(Abstract).